Clinical Trials
53 trialsSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Pfizer
TRIDENT-1
Turning Point Therapeutics, Inc.
GRECCAR 5
University Hospital, Bordeaux
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
Purdue University
BFT in LARS
National Taiwan University Hospital
SECURE
Medtronic - MITG
ALLAN
Lund University Hospital
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
Pfizer
ARROW
Hoffmann-La Roche
CRC-DRAW
New Day Diagnostics
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
Thomas Jefferson University
PERECARE
GEM Hospital & Research Center
Physical Activity in Rectal Cancer Survivors
Abramson Cancer Center at Penn Medicine
Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Duke University
SGM-CBM
Leiden University Medical Center
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Kyowa Kirin Co., Ltd.
ASPIRIN
University Hospital, Antwerp
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Catalysis SL
CanStem303C
Sumitomo Pharma America, Inc.
ALpha-T
Hoffmann-La Roche
Translation of the International Consensus Definition of LARS Into a Bowl Dysfunction Severity Scoring Tool (New LARS Score)
Cardiff and Vale University Health Board
LOSAPEX
University of Aarhus
SEPTRALU
Sociedad Española de Medicina Nuclear e Imagen Molecular
PORTLARS
Sixth Affiliated Hospital, Sun Yat-sen University
The OPERa Study: Evaluating QoL After Rectal Cancer Surgery
Jewish General Hospital
ALTER-C-002
Zhejiang University
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
State Scientific Centre of Coloproctology, Russian Federation
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
TINGLE
Cedars-Sinai Medical Center
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feasibility Bowel Dysfunction Program After Low Anterior Resection
Fox Chase Cancer Center
CCR-microbiota
Maimónides Biomedical Research Institute of Córdoba
CLEAR-C
Zhejiang University
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Isofol Medical AB
LongLARS
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
Erings™
Portsmouth Hospitals NHS Trust
MERCURY II
Royal Marsden NHS Foundation Trust
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
MARVEL
Royal Marsden NHS Foundation Trust
B-ADENOMA
South Tyneside and Sunderland NHS Foundation Trust
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Exact Sciences Corporation
NEOLAR
Zealand University Hospital
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
Microbiome Test for the Detection of Colorectal Polyps and Cancer
Metabiomics Corp
OCEANIA
Exact Sciences Corporation
PMCRBDSPS
Peking University People's Hospital
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
Exact Sciences Corporation
DeeP-C
Exact Sciences Corporation
Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Swedish Medical Center
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Exact Sciences Corporation